ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
National Research Corporation

National Research Corporation (NRC)

23.935
-0.725
( -2.94% )
Updated: 15:24:29

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
23.935
Bid
23.89
Ask
23.99
Volume
51,314
23.84 Day's Range 25.01
21.7307 52 Week Range 47.25
Market Cap
Previous Close
24.66
Open
24.63
Last Trade
1
@
23.97
Last Trade Time
15:26:59
Financial Volume
$ 1,245,220
VWAP
24.2667
Average Volume (3m)
112,330
Shares Outstanding
23,877,315
Dividend Yield
2.01%
PE Ratio
18.52
Earnings Per Share (EPS)
1.3
Revenue
148.58M
Net Profit
30.97M

About National Research Corporation

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solut... National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. Show more

Sector
Coml Physical, Biologcl Resh
Industry
Testing Laboratories
Headquarters
Milwaukee, Wisconsin, USA
Founded
2004
National Research Corporation is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker NRC. The last closing price for National Research was $24.66. Over the last year, National Research shares have traded in a share price range of $ 21.7307 to $ 47.25.

National Research currently has 23,877,315 shares outstanding. The market capitalization of National Research is $588.81 million. National Research has a price to earnings ratio (PE ratio) of 18.52.

NRC Latest News

National Research Corporation Announces First Quarter Results

National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: “NRC continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.2250.94896668072523.7125.8823.398323124.74626303CS
40.9053.9296569691723.0325.8821.730712059923.43212266CS
12-10.995-31.477240194734.9335.8121.730711233025.70936486CS
26-16.035-40.117588191139.974221.73078398830.64854482CS
52-19.275-44.607729692243.2147.2521.73076913034.98989247CS
156-27.975-53.891350414251.9155.6721.73074889138.13284489CS
260-42.155-63.784233620866.0971.352521.73074387943.58570155CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWOU2U Inc
$ 3.244
(159.52%)
134.01M
LIPOLipella Pharmaceuticals Inc
$ 0.8987
(122.40%)
189.6M
TIVCTivic Health Systems Inc
$ 0.7688
(70.09%)
97.71M
NIPGNIP Group Inc
 14.65
(62.42%)
6.38M
ISPOInspirato Inc
$ 5.2301
(50.29%)
2.51M
CGTXCognition Therapeutics Inc
$ 1.405
(-40.72%)
24.43M
GRIGRI Bio Inc
$ 0.8726
(-30.75%)
714.35k
CEROCERo Therapeutics Holdings Inc
$ 0.1793
(-29.96%)
7.47M
NXTTNext Technology Holding Inc
$ 1.1302
(-26.13%)
527.47k
VTVTvTv Therapeutics Inc
$ 16.24
(-23.40%)
128.93k
NVDANVIDIA Corporation
$ 112.05
(-0.89%)
206.29M
LIPOLipella Pharmaceuticals Inc
$ 0.8987
(122.40%)
189.6M
SQQQProShares UltraPro Short QQQ
$ 9.005
(-1.04%)
140.28M
TWOU2U Inc
$ 3.244
(159.52%)
134.01M
NLSPNLS Pharmaceutics Ltd
$ 0.2252
(18.53%)
116.37M

Discussion

View Full Feed
Bost Bost 3 minutes ago
Yeah it's in title only and jb is still calling the shots with his majority shares then nothing has changed. He needs to relinquish controll for this to do anything. It also even furthers giving himself an out and putting all the blame on Kevin. Great step if it's done right though.
UBQU
Bost Bost 3 minutes ago
Yeah it's in title only and jb is still calling the shots with his majority shares then nothing has changed. He needs to relinquish controll for this to do anything. It also even furthers giving himself an out and putting all the blame on Kevin. Great step if it's done right though.
UBQU
MartinLutherKing MartinLutherKing 4 minutes ago
The need to pay NYSE 260K to be compliant
FOXO
Kitfox Kitfox 4 minutes ago
We are Golden. Just Patience and Faith
IGPK
Mark Mark 4 minutes ago
$PRST .06 supposedly CEO on Bloomburg @ 4:10pm
PRST
Lime Time Lime Time 4 minutes ago
Wait, how is that possible? Is it AON (all or none)? Those usually don't show.

Are you sure it's on HQGE and not another stock? I've been following L1 on many tickers, and it's very accurate, occasionally there is a blip on 9:30am ET Market Open. Other than that, the buys and sells go
HQGE
knrorrel knrorrel 4 minutes ago
I will hold onto this share $NWPN and it doesn't matter if I have to wait half a year or a whole year. But I have the feeling. Something is developing here and something is happening here and sooner or later people will jump in with the news flow and I want to be there from the start. That's why I b
NWPN
evenpar evenpar 4 minutes ago
Exactly if you've been here as long as me you know earnings mean absolutely nothing and the better the earnings the bigger the drop.
FNMA
MoneyMan MoneyMan 4 minutes ago
Sincerity Applied Materials Announces Conference Call
https://www.otcmarkets.com/stock/SINC/news/Sincerity-Applied-Materials-Announces-Conference-Call?id=448271
SINC
MoCubano MoCubano 4 minutes ago
Lower your voice, you're annoying.
FNMA
Hitman970 Hitman970 5 minutes ago
This is going to 50$
CRWD
SorcererGuru44 SorcererGuru44 5 minutes ago
Let me break this down the best I can.

Derivative action - This is the case filed by Chul Yang. Case # 2:23-cv-00235 which can be found here: https://www.pacermonitor.com/case/47490874/YANG_v_DURRANT_et_al

The "Claims"- is the essentially the objection filed by the comm
abrois abrois 5 minutes ago
increased volume today ,,
STEV
mmayr mmayr 5 minutes ago
Media and Democrats Work Overtime to Rebrand Kamala Harris as Cool and Competent, with Ben Shapiro

[yt]FGWxD7mP9WQ[/yt]

https://www.youtube.com/watch?v=FGWxD7mP9WQ
Investor2014 Investor2014 5 minutes ago
The problem is that the 'news' isn't as great as the WGT retail biotech 'investors' here believe. There is some learning and understanding to work on...
AVXL
stock1ace1 stock1ace1 5 minutes ago
Sxtc $1.15s
RedShoulder RedShoulder 5 minutes ago
nidan, thanks for posting this information:

This is THE big win for Anavex, no other AD drug slows the brain matter losses. No one wants to lose brain cappacity.

"Blarcamesine significantly slowed brain atrophy in key regions of interest, including the whole brain by
AVXL
Carjockey2 Carjockey2 5 minutes ago
Like I've stated a couple of times, obviously, I want a green close, but it's all about the super 8K for me.

Patience!!!!

HIRU
newman2021 newman2021 5 minutes ago
Was Bernie untouchable at one time??
NWBO
rich2 rich2 5 minutes ago
Love your old proverb

All that should be said now is rest in peace (RIP)

anything else is shameful
MXSG
PennyMillions852 PennyMillions852 5 minutes ago
Ouch!!!!!
IGPK
vdog1776 vdog1776 5 minutes ago
YOU
VXIT
Acme Investments Acme Investments 6 minutes ago
You've seen this movie before!! Collecting the last of the retirement funds before the drop!!
HIRU
knrorrel knrorrel 6 minutes ago
The experienced traders know exactly that with trips shares, "patience" is the most important thing in order to get the biggest gains / profit


NWPN